CorMedix Inc.(CRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRMD CorMedix Inc.

Closed 01-13 16:00:00 EST

7.06

-0.09

-1.26%

盘后7.16

+0.10+1.42%

19:58 EST

High7.31	Low7.05	Vol2.76M
Open7.15	D1 Closing7.15	Amplitude3.64%
Mkt Cap556.25M	Tradable Cap520.29M	Total Shares78.79M
T/O19.69M	T/O Rate3.75%	Tradable Shares73.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRMD","market":"US","secType":"STK","nameCN":"CorMedix Inc.","latestPrice":7.06,"timestamp":1768338000000,"preClose":7.15,"halted":0,"volume":2763683,"hourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.06,"latestTime":"19:58 EST","volume":50472,"amount":356838.8914,"timestamp":1768352319001},"delay":0,"floatShares":73694900,"shares":78789045,"eps":2.0624602,"marketStatus":"Closed","change":-0.09,"latestTime":"01-13 16:00:00 EST","open":7.15,"high":7.31,"low":7.05,"amount":19692684.017526,"amplitude":0.036364,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.0624602,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768381200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1273723200000,"exchange":"NASDAQ","adjPreClose":7.15,"preHourTrading":{"tag":"盘前","latestPrice":7.15,"preClose":7.15,"latestTime":"09:29 EST","volume":19164,"amount":137374.65609479998,"timestamp":1768314599912},"postHourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.06,"latestTime":"19:58 EST","volume":50472,"amount":356838.8914,"timestamp":1768352319001},"volumeRatio":0.314888,"impliedVol":0.8082,"impliedVolPercentile":0.6295},"requestUrl":"/m/hq/s/CRMD","defaultTab":"news","newsList":[{"id":"2603633968","title":"CorMedix (CRMD) Valuation After New Leadership Moves And 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2603633968","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603633968?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:16","pubTimestamp":1768302962,"startTime":"0","endTime":"0","summary":"Leadership moves and fresh guidance at CorMedix\nCorMedix (CRMD) is drawing attention after naming CEO Joseph Todisco as Chairman and issuing 2026 revenue guidance of US$300 million to US$320 million, alongside appointing Mike Seckler as EVP & Chief Commercial Officer.\nSee our latest analysis for CorMedix.\nThe leadership changes and fresh 2026 revenue guidance arrive after a sharp pullback in CorMedix’s share price. The 7 day share price return shows a decline of 36.50% and the year to date...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crmd/cormedix/news/cormedix-crmd-valuation-after-new-leadership-moves-and-2026","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crmd/cormedix/news/cormedix-crmd-valuation-after-new-leadership-moves-and-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRMD"],"gpt_icon":0},{"id":"2603085579","title":"Analysts Conflicted on These Healthcare Names: Cormedix (CRMD), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603085579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603085579?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:20","pubTimestamp":1768274412,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cormedix (CRMD – Research Report), BioMarin Pharma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cormedix-crmd-biomarin-pharmaceutical-bmrn-and-acadia-pharmaceuticals-acad-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cormedix-crmd-biomarin-pharmaceutical-bmrn-and-acadia-pharmaceuticals-acad-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","XBI","BK4137","BK4566","HCSG","LU2065171402.SGD","XLV","IE00B19Z3B42.SGD","BK4139","BK4585","IE00B7SZLL34.SGD","LU0029874061.USD","LU0128526141.USD","LABU","CRMD","BK4007","ACAD","BK4588","IE00B19Z3581.USD","BK4581","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","BMRN"],"gpt_icon":0},{"id":"1134045879","title":"Stock Track | CorMedix Inc. Plummets 5.24% Intraday After Leerink Partners Slashes Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1134045879","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134045879?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:36","pubTimestamp":1768228577,"startTime":"0","endTime":"0","summary":"CorMedix Inc. (CRMD) saw its stock plummet by 5.24% during intraday trading on Monday, following a significant target price cut by Leerink Partners.The investment firm reduced its target price for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CRMD"],"gpt_icon":0},{"id":"2602512187","title":"CorMedix Inc : Leerink Partners Cuts Target Price to $15 From $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512187?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:28","pubTimestamp":1768220885,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD1AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"1143784563","title":"Stock Track | CorMedix Inc. Soars 5.46% Intraday as CEO Prepares for J.P. Morgan Healthcare Conference Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1143784563","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143784563?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:32","pubTimestamp":1767969140,"startTime":"0","endTime":"0","summary":"CorMedix Inc. (CRMD) saw its stock price surge by 5.46% during Friday's intraday session, reflecting strong investor optimism.The rally appears to be driven by the announcement that CorMedix's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CRMD"],"gpt_icon":0},{"id":"2602376096","title":"CorMedix CEO to Present Corporate Overview at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376096?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:30","pubTimestamp":1767965451,"startTime":"0","endTime":"0","summary":"CorMedix Inc. will present a corporate overview at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30pm PST. Chairman and CEO Joseph Todisco is scheduled to deliver the presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CorMedix Inc. published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL3l57TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","BK4585","LU2095319765.USD","BK4007","SG9999014021.USD","BK4588","CRMD","BK4112","IE00BKPKM429.USD","SG9999014039.USD"],"gpt_icon":0},{"id":"2602339706","title":"CorMedix Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2602339706","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602339706?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:57","pubTimestamp":1767902220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 14:57 ET (19:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2602397269","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2602397269","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602397269?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:37","pubTimestamp":1767901029,"startTime":"0","endTime":"0","summary":"CorMedix  reported Q4 preliminary net revenue on Thursday, a touch below the average analyst estimate compiled by FactSet, and its forecast range for full-year 2026 sales also missed consensus.Shares of the health care firm sank 33% following an increase in intraday trading volume to over 19 million from a daily average of about 2.78 million.Acuity  shares sank 14% after the lighting and building management solutions provider left its full-year adjusted earnings and sales outlook unchanged, taking the shine off its fiscal Q1 adjusted earnings beat.More than 822,000 shares of the company traded intraday compared with a daily average of about 249,000.Genelux  said Thursday it priced an underwritten public offering of about 6.67 million shares at $3 each, targeting gross proceeds of roughly $20.0 million.Shares of the biopharmaceutical company slumped 18% as intraday trading volume soared to over 1.23 million from a daily average of about 237,000.Price: 7.54, Change: -3.63, Percent Change","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7062","LU0203347892.USD","BK4096","CRMD","LU0054578231.USD","AYI.AU","BK4139","BK4007","AYI","LU0203345920.USD","GNLX"],"gpt_icon":0},{"id":"2602394547","title":"CorMedix price target lowered to $16 from $20 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2602394547","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602394547?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:45","pubTimestamp":1767894322,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on CorMedix (CRMD) to $16 from $20 and keeps a Buy rating on the shares after the company introduced a FY26 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cormedix-price-target-lowered-to-16-from-20-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cormedix-price-target-lowered-to-16-from-20-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2602399794","title":"CorMedix Slides on Preliminary FY25 Results, FY26 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602399794","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602399794?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:07","pubTimestamp":1767892020,"startTime":"0","endTime":"0","summary":"Shares for CorMedix fell after the biopharmaceutical company guided for a potential decline in revenue in 2026.The stock was down 35%, at $7.26, midday Thursday, on pace for its worst percentage decrease since March 2025.CorMedix on Thursday guided for revenue between $300 million and $320 million for fiscal 2026, compared with $310 million in net revenue for fiscal 2025, according to the company's unaudited preliminary results. Analysts polled FactSet expected $312.9 million for fiscal 2025 and $423.3 million for 2026.The Berkeley Heights, N.J., company said it expects the level of reimbursement to institutions treating dialysis patients to significantly decline on July 1, as calculated by the Centers for Medicare & Medicaid Services. The new math would lead to a reduction in net pricing for the company's catheter lock, DefenCath, in the third and fourth quarters.\"If CMS utilizes the same methodology to calculate\" an add-on adjustment for DefenCath after Jan. 1, 2027, the company expe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2601367835","title":"CorMedix Reports Q4 Preliminary Net Revenue, Provides Guidance; Names CEO Joseph Todisco Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2601367835","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601367835?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:43","pubTimestamp":1767879793,"startTime":"0","endTime":"0","summary":"CorMedix  reported Q4 preliminary net revenue Thursday of $127 million.Analysts surveyed by FactSet expected $128.3 million.The company said it expects 2026 revenue of $300 million to $320 million.Analysts surveyed by FactSet expect $435.7 million.CorMedix also named Chief Executive Joseph Todisco chairman of the board of directors, succeeding Myron Kaplan, who will become lead independent director, which is a new position on the board.Shares of CorMedix were down more than 8% pre-bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2601236216","title":"BRIEF-Cormedix Therapeutics Announces Preliminary Fourth Quarter And Full Year 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2601236216","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601236216?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:33","pubTimestamp":1767879220,"startTime":"0","endTime":"0","summary":"BRIEF-Cormedix Therapeutics Announces Preliminary Fourth Quarter And Full Year 2025 Results Jan 8 (Reuters) - CorMedix Inc CRMD.O:CORMEDIX THERAPEUTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA9NTPXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2601647293","title":"GUIDANCE: (CRMD) CorMedix Expects 2026 Revenue Range $300M to $320M, vs. FactSet Est of $435.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2601647293","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601647293?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:18","pubTimestamp":1767878320,"startTime":"0","endTime":"0","summary":"GUIDANCE: (CRMD) CorMedix Expects 2026 Revenue Range $300M to $320M, vs. FactSet Est of $435.7","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRMD"],"gpt_icon":0},{"id":"2601364726","title":"Earnings Flash (CRMD) CorMedix Posts Q4 Preliminary Net Revenue $127M, vs. FactSet Est of $128.3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364726","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364726?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:17","pubTimestamp":1767878255,"startTime":"0","endTime":"0","summary":"Earnings Flash (CRMD) CorMedix Posts Q4 Preliminary Net Revenue $127M, vs. FactSet Est of $128.3M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRMD"],"gpt_icon":0},{"id":"2601362336","title":"CorMedix CEO Joseph Todisco signs extended employment contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362336","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362336?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:17","pubTimestamp":1767878222,"startTime":"0","endTime":"0","summary":"CorMedix (CRMD) announced an addition to its executive leadership team and updates to its Board of Directors. CorMedix CEO Joseph Todisco has signe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cormedix-ceo-joseph-todisco-signs-extended-employment-contract-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cormedix-ceo-joseph-todisco-signs-extended-employment-contract-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRMD","BK4007"],"gpt_icon":0},{"id":"2601628063","title":"CorMedix appoints Mike Seckler as CCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2601628063","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601628063?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:16","pubTimestamp":1767878164,"startTime":"0","endTime":"0","summary":"CorMedix (CRMD) announced the appointment of Mr. Mike Seckler to the role of EVP & Chief Commercial Officer. Mr. Seckler joins CorMedix with a weal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cormedix-appoints-mike-seckler-as-cco-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cormedix-appoints-mike-seckler-as-cco-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2249611893.SGD","BK4007","BK4009","LU2294711713.HKD","LU2506951792.HKD","CCO","LU0823414551.USD","LU0823414478.USD","CRMD","LU2357125470.USD"],"gpt_icon":0},{"id":"2601649373","title":"CorMedix Names Joseph Todisco Chairman and Appoints Mike Seckler Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601649373","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601649373?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877514,"startTime":"0","endTime":"0","summary":"CorMedix Inc. announced that CEO Joseph Todisco will also assume the role of Chairman of the Board, succeeding Myron Kaplan, who becomes Lead Independent Director. Additionally, Mike Seckler has been appointed as Executive Vice President and Chief Commercial Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CorMedix Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL6qK0dv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014039.USD","CRMD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","BK4007","NDAQ","SG9999014013.SGD","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2601364943","title":"CorMedix Inc - CEO Joseph Todisco Signs Extended Employment Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364943?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4RLCKK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2601236491","title":"CorMedix Inc - Joseph Todisco Assumes Role of Chairman of the Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2601236491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601236491?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4RLCKK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CRMD"],"gpt_icon":0},{"id":"2601103364","title":"Press Release: CorMedix Therapeutics Announces Leadership and Board Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2601103364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601103364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:05","pubTimestamp":1767877500,"startTime":"0","endTime":"0","summary":"BERKELEY HEIGHTS, N.J., Jan. 08, 2026  -- CorMedix Therapeutics , a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced an addition to its executive leadership team and updates to its Board of Directors. CorMedix CEO Joseph Todisco has signed an extended employment contract, reaffirming his long-term commitment to the organization. In addition to his role as CEO, Mr. Todisco will also assume the role of Chairman of the Board of Directors, succeeding Myron Kaplan. Mr. Kaplan will transition into a newly created board position of Lead Independent Director.CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath  for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4099","BK4139","BK4588","BK4604","LENZ","R","BK4007","BK4539","BK4232","TM","CRMD","BK4555","BK4585","03160"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cormedix.com","stockEarnings":[{"period":"1week","weight":-0.4135},{"period":"1month","weight":-0.3777},{"period":"3month","weight":-0.3216},{"period":"6month","weight":-0.3576},{"period":"1year","weight":-0.361},{"period":"ytd","weight":-0.3852}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.130015},{"month":2,"riseRate":0.533333,"avgChangeRate":0.076401},{"month":3,"riseRate":0.533333,"avgChangeRate":0.047277},{"month":4,"riseRate":0.466667,"avgChangeRate":-0.013888},{"month":5,"riseRate":0.2,"avgChangeRate":-0.123071},{"month":6,"riseRate":0.5625,"avgChangeRate":0.053114},{"month":7,"riseRate":0.4375,"avgChangeRate":0.055385},{"month":8,"riseRate":0.5625,"avgChangeRate":0.025363},{"month":9,"riseRate":0.375,"avgChangeRate":0.027376},{"month":10,"riseRate":0.4375,"avgChangeRate":0.043001},{"month":11,"riseRate":0.4375,"avgChangeRate":0.046811},{"month":12,"riseRate":0.4375,"avgChangeRate":0.057824}],"exchange":"NASDAQ","name":"CorMedix Inc.","nameEN":"CorMedix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CorMedix Inc.(CRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CorMedix Inc.(CRMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CorMedix Inc.,CRMD,CorMedix Inc.股票,CorMedix Inc.股票老虎,CorMedix Inc.股票老虎国际,CorMedix Inc.行情,CorMedix Inc.股票行情,CorMedix Inc.股价,CorMedix Inc.股市,CorMedix Inc.股票价格,CorMedix Inc.股票交易,CorMedix Inc.股票购买,CorMedix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CorMedix Inc.(CRMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CorMedix Inc.(CRMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction